Active Ingredient(s):Levalbuterol FDA Approved: * March 25, 1999 Pharm Company: *SEPRACOR Category:Asthma
Levosalbutamol, also known as levalbuterol, is a short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Evidence does not show that levosalbutamol works better than salbutamol; thus there may not be sufficient justification for prescribing it.
The drug is the (R)-(−)-enantiomer of its prototype drug salbutamol. It is available in some countries in generic formulations from pharmaceutical compa...
* May have multiple approval dates, manufacturers, or labelers. 4 Discussions